Kuritzkes DR - Search Results

1

Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.

Kuritzkes DR, Parenti D, Ward DJ, Rachlis A, Wong RJ, Mallon KP, Rich WJ, Jacobson MA. Kuritzkes DR, et al. AIDS. 1998 Jan 1;12(1):65-74. doi: 10.1097/00002030-199801000-00008. AIDS. 1998. PMID: 9456256 Clinical Trial.

2

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

Kuritzkes DR, Quinn JB, Benoit SL, Shugarts DL, Griffin A, Bakhtiari M, Poticha D, Eron JJ, Fallon MA, Rubin M. Kuritzkes DR, et al. AIDS. 1996 Aug;10(9):975-81. doi: 10.1097/00002030-199610090-00007. AIDS. 1996. PMID: 8853730 Clinical Trial.

3

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.

Phillips AN, Eron J, Bartlett J, Kuritzkes DR, Johnson VA, Gilbert C, Johnson J, Keller A, Hill AM. Phillips AN, et al. Among authors: kuritzkes dr. AIDS. 1997 Feb;11(2):169-75. doi: 10.1097/00002030-199702000-00006. AIDS. 1997. PMID: 9030363

4

Clinical significance of drug resistance in HIV-1 infection.

Kuritzkes DR. Kuritzkes DR. AIDS. 1996 Dec;10 Suppl 5:S27-31. doi: 10.1097/00002030-199612005-00005. AIDS. 1996. PMID: 9030393 Review.

5

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.

Kuritzkes DR, Marschner I, Johnson VA, Bassett R, Eron JJ, Fischl MA, Murphy RL, Fife K, Maenza J, Rosandich ME, Bell D, Wood K, Sommadossi JP, Pettinelli C. Kuritzkes DR, et al. AIDS. 1999 Apr 16;13(6):685-94. doi: 10.1097/00002030-199904160-00009. AIDS. 1999. PMID: 10397563 Clinical Trial.

6

HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication.

Patki AH, Purvis SF, Valdez H, Spritzler J, Connick E, Kuritzkes DR, Kessler H, Fox L, St Clair M, Landay A, Lederman MM. Patki AH, et al. Among authors: kuritzkes dr. AIDS. 1999 Jul 9;13(10):1177-85. doi: 10.1097/00002030-199907090-00005. AIDS. 1999. PMID: 10416520 Clinical Trial.

7

Viral kinetics: implications for treatment.

Young B, Kuritzkes DR. Young B, et al. Among authors: kuritzkes dr. AIDS. 1999 Sep;13 Suppl 1:S11-7. AIDS. 1999. PMID: 10546781 Review.

8

Clinical experience with Filgrastim in AIDS.

Kuritzkes DR. Kuritzkes DR. J Hematother Stem Cell Res. 1999;8 Suppl 1:S17-9. doi: 10.1089/152581699319876. J Hematother Stem Cell Res. 1999. PMID: 10596031 Review.

9

Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team.

Campbell TB, Sevin A, Coombs RW, Peterson GC, Rosandich M, Kuritzkes DR, Mladenovic J, Landay A, Wong R, Ambruso D, Miles S, Pomerantz RJ, Schooley RT. Campbell TB, et al. Among authors: kuritzkes dr. Blood. 2000 Jan 1;95(1):48-55. Blood. 2000. PMID: 10607683 Free article.

10

Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.

Kuritzkes DR. Kuritzkes DR. Clin Infect Dis. 2000 Feb;30(2):256-60. doi: 10.1086/313642. Clin Infect Dis. 2000. PMID: 10671324 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters